Goldman Sachs’s Biote Corp BTMD Stock Holding History
Bought
Maintained
Sold
Other funds holding BTMD
3C
BP
VCM
GC
Goldman Sachs's BTMD Position: Q1 2026 in Review
Goldman Sachs reduced its Biote Corp (BTMD) stake by 4.6% in Q1 2026, selling an estimated $9.83K and leaving 100,609 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #6161.
Goldman Sachs first reported a position in BTMD in Q2 2021 and has held it in 17 quarters since. The position peaked at $6.17M in Q1 2022. 84 funds tracked by Wall St. Rank hold BTMD as of Q1 2026.
- Goldman Sachs held 100,609 shares of Biote Corp worth $136K as of Q1 2026.
- Goldman Sachs sold 4,893 Biote Corp shares in Q1 2026, an estimated $9.83K.
- Biote Corp made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6161 holding.
- Goldman Sachs first reported a position in Biote Corp in Q2 2021 and has held it in 17 quarters since.
- Goldman Sachs's Biote Corp position peaked at $6.17M in Q1 2022.
- 84 funds tracked by Wall St. Rank held Biote Corp as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.